Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 80c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. SPY
7. BA
8. HOOD
9. INTC
10. JBLU

Go back to Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 80c

Fulgent Genetics Reports Third Quarter Financial Results

November 9, 2021 4:05 PM EST

Revenue grows 124% year-over-year to $227.9 million Core Revenue grows 292% year-over-year to $40.1 million Raises Full Year Revenue guidance to $930 million from $800 million, given recent strength in core and COVID-19 business

TEMPLE CITY, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced financial results for its third quarter ended September 30, 2021.

Third Quarter 2021 Results:

Revenue of $227.9 million,... More